000185541 001__ 185541
000185541 005__ 20230208173513.0
000185541 0247_ $$2CORDIS$$aG:(EU-Grant)712214$$d712214
000185541 0247_ $$2CORDIS$$aG:(EU-Call)H2020-SMEINST-1-2015$$dH2020-SMEINST-1-2015
000185541 0247_ $$2originalID$$acorda__h2020::712214
000185541 035__ $$aG:(EU-Grant)712214
000185541 150__ $$aFrom plants for plants: enhancing crops potential and resilience by reliable new generation biostimulants$$y2016-02-01 - 2016-08-31
000185541 371__ $$aLANDLAB SRL$$bLandlab$$dItaly$$ehttp://www.landlab.net$$vCORDIS
000185541 372__ $$aH2020-SMEINST-1-2015$$s2016-02-01$$t2016-08-31
000185541 450__ $$aPlants for Plants$$wd$$y2016-02-01 - 2016-08-31
000185541 5101_ $$0I:(DE-588b)5098525-5$$2CORDIS$$aEuropean Union
000185541 680__ $$aObjective of the innovation project is the worldwide market introduction of a new generation of plant-derived biostimulants able to enhance crops yields without resorting to chemical inputs and to improve plant resilience to climate change in a stable, reliable way.  
With the conventional cropping systems, the potential of cultivated plants is close to the maximum. Moreover, climate change impacts (drought, extreme temperatures, etc.) are on the rise, putting further constraints to yields and challenging food security. Meanwhile many fertilizers are outlawed by ever-stricter environmental laws, leaving farmers and industry in search for alternatives. Pressures which are reinforced by a rising demand for healthy and eco-friendly products. 
Landlab biostimulants have been designed as an answer to these challenges. Breakthrough is the opening of a new and precise pathway, much more similar to the pharmaceutical/natural product industry than to current agricultural one. This will lead to the buildup of a strongly integrated source-to-sink production chain, able to generate a flow of innovative products, specifically tailored on critical stages and conditions of manifold crops and supported by accurate identification of their active compounds and by efficacy studies, as to counter the main drawback of state-of-the-art biostimulants: their inconsistent stability of performances.
In order to transform these R&D outcomes into successful products, 1st aim of the feasibility study is to assess the most convenient direction of prototype demonstration and market introduction efforts. Technical and market data will be crossed with cost analysis to identify which biostimulants launch first and benchmark the potential business models. Then matured information will be elaborated into a business plan and commercialization strategy, to be validated in Phase 2. 
After the launch, Landlab expects to double its growth pace, triggering jobs for highly skilled scientists and investments.
000185541 909CO $$ooai:juser.fz-juelich.de:282821$$pauthority$$pauthority:GRANT
000185541 909CO $$ooai:juser.fz-juelich.de:282821
000185541 970__ $$aoai:dnet:corda__h2020::5880e9e475981674ca3540d96366b62a
000185541 980__ $$aG
000185541 980__ $$aCORDIS
000185541 980__ $$aAUTHORITY